Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 2Phase EARLY_PHASE1 1Phase 1/2 1

Status

Completed 13Withdrawn 4Terminated 4Unknown 2Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Rectal Neoplasms 1Prostate Cancer Metastatic Castration Resistant 1Neoplasms 1Communicable Diseases 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

Cyclophosphamide 166Docetaxel 154Bevacizumab 153Carboplatin 148Gemcitabine 146Cisplatin 146pembrolizumab 142Radiotherapy 135Paclitaxel 132Capecitabine 122Rituximab 115Oxaliplatin 104Fluorouracil 103Nivolumab 94Irinotecan 85Doxorubicin 85Pemetrexed 83Leucovorin 82Dexamethasone 82fludarabine 74fludarabine phosphate 72Bortezomib 69Etoposide 67Erlotinib Hydrochloride 66Cetuximab 65Methotrexate 58Trastuzumab 56Cytarabine 54Lenalidomide 50Everolimus 49

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Terminated × Curcumin × Clear all
NCT02944578 2024-10-29

Topical Curcumin for Precancer Cervical Lesions

Emory University

Phase 2 Terminated
7 enrolled 7 charts

Communicable Diseases, Neoplasms

NCT00745134 2023-09-28

Radiation Therapy and Capecitabine With or Without Curcumin Before Surgery in Treating Patients With Rectal Cancer

M.D. Anderson Cancer Center

Phase 2 Terminated
22 enrolled 16 charts
Gastrointestinal

Rectal Neoplasms

NCT00852332 2018-07-24

Docetaxel With or Without a Phytochemical in Treating Patients With Breast Cancer

Centre Jean Perrin

Phase 2 Terminated
42 enrolled
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT02095717 2018-07-24

CURTAXEL

Centre Jean Perrin

Phase 2 Terminated
50 enrolled
Genitourinary

Prostate Cancer Metastatic Castration Resistant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡